PolyOne Investor Presentation November 2017 POLYONE CORPORATION 2  In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. You are advised to consult any further disclosures we make on related subjects in our reports on Form 10-Q, 8-K and 10-K that we provide to the Securities and Exchange Commission. In addition, operating income before special items and adjusted EPS are components of various PolyOne annual and long-term employee incentive plans.  A reconciliation of each non-GAAP financial measure with the most directly comparable GAAP financial measure is attached to this presentation which is posted on our website at www.polyone.com.  All DSS results are now reported under discontinued operations.

The data is reported as average force over 2 inch (5.08mm) of pulling at speed of 2"/min (5.08mm/min). INSERT MOLDING Insert molding data is reported in Table 3 and Figures 4 through 9. TWO-SHOT MOLDING Data is reported in Table 4.

EXCELENCIA OPERATIVA Nos brinda las herramientas necesarias para responder a las opiniones de los clientes con una mejora continua.

The company reported third quarter sales of $754 million compared to $823 million in the prior year. For more information, visit https://www.avient.com. https://www.avient.com/ 5 Forward-looking Statements In this press release, statements that are not reported financial results or other historical information are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. You are advised to consult any further disclosures we make on related subjects in our reports on Form 10-Q, 8-K and 10-K that we provide to the Securities and Exchange Commission. 6 Investor Relations Contact: Giuseppe (Joe) Di Salvo Vice President, Treasurer and Investor Relations Avient Corporation +1 440-930-1921 giuseppe.disalvo@avient.com Media Contact: Kyle G.

The company reported first quarter sales of $829.0 million compared to $845.7 million in the prior year quarter. For more information, visit https://www.avient.com. https://www.avient.com/news-events https://www.avient.com/ 4 Forward-looking Statements In this press release, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. You are advised to consult any further disclosures we make on related subjects in our reports on Form 10-Q, 8-K and 10-K that we provide to the Securities and Exchange Commission. 5 Investor Relations Contact: Giuseppe (Joe) Di Salvo Vice President, Treasurer and Investor Relations Avient Corporation +1 440-930-1921 giuseppe.disalvo@avient.com Media Contact: Kyle G.

Produced with ingredients tested to European Pharmacopeia protocols, the range is targeted for use in the production of PP and PE pharma containers for parenteral, ocular, and nasal drugs. 

Create attractive, haze-free PET containers that customers love and that fly off the shelves

From boat decks to RV bunks, and shipping containers to military shelters, our high fiber volume, glass-reinforced thermoplastic panels, continuous resin transfer molding (CRTM™) thermoset sandwich panels and ballistic resistant panels can streamline production, decrease system costs, and reduce weight across a wide range of applications.

The chart below contains products that benefit from both LSR and TPE materials.

The chart below contains products that benefit from both LSR and TPE materials.